Cortechs.ai Partners with Mermaid Beach Radiology to Bring Precision AI Imaging Solutions to Their MRI and CT Services

San Diego, CA, Nov. 25, 2024 – Cortechs.ai, a leading provider of AI-powered imaging solutions, is excited to announce that Mermaid Beach Radiology has integrated Cortechs.ai’s advanced imaging software into its MRI and CT offerings. This partnership introduces precision-driven brain segmentation, volumetric analysis, and longitudinal tracking capabilities to Mermaid Beach Radiology, enabling faster, more accurate insights to enhance patient care.
This collaboration showcases Mermaid Beach Radiology’s commitment to innovation in diagnostic imaging, using Cortechs.ai’s best-in-class solutions to provide a higher standard of care for the Gold Coast community. Cortechs.ai’s NeuroQuant® solution, powered by deep learning and its proprietary Dynamic Atlas™ technology, equips Mermaid Beach Radiology’s team with several transformative features:

  • AI-Powered Brain Segmentation: Delivers accurate 3D T1 MRI brain segmentation, with age norms for patients aged 3 to 100 years, supporting both clinical and research applications.
  • Customizable Volumetric Reports: Generates tailored NeuroQuant® reports suited to each patient’s unique needs, enabling more personalized care.
  • Comprehensive Disease Monitoring: Supports longitudinal tracking and visualization, empowering clinicians to monitor disease progression over time with data-backed precision.

Kyle Frye, CEO of Cortechs.ai, shared his enthusiasm for the collaboration, stating, “Working with Mermaid Beach Radiology is a fantastic opportunity to expand the reach of our AI-powered solutions in Australia and beyond. Through this partnership, we are excited to advance diagnostic excellence and deliver the quality of insights that make a real difference in people’s lives.”

“Cortechs.ai’s software significantly enhances patient care by providing faster, more reliable diagnostic insights,” said Dr. Zane Sherif, Founding Radiologist at Mermaid Beach Radiology. “With the addition of NeuroQuant®, we’re improving both our workflow efficiency and our ability to make accurate, informed diagnoses, ultimately benefiting our patients and raising the standard of care we provide.”

Cortechs.ai is committed to revolutionizing healthcare by providing cutting-edge imaging technology that empowers radiologists to deliver precise, efficient, and data-driven diagnoses. Our AI-powered solutions are designed to enhance diagnostic accuracy, streamline workflows, and ultimately improve patient outcomes. The integration of Cortechs.ai’s software into Mermaid Beach Radiology’s practice underscores the growing global shift toward AI-driven healthcare solutions, setting a new standard for diagnostic excellence and raising the bar for care delivery worldwide. This partnership highlights how AI can play a pivotal role in advancing healthcare systems and improving patient experiences across the globe.

About Cortechs.ai
Cortechs.ai is a leader in AI applications in radiology. Cortechs.ai uses cutting-edge technologies in medical imaging to revolutionize disease screening and early detection so patients can enjoy longer, healthier lives. The company develops and markets breakthrough medical device software that quantifies and tracks neurodegenerative diseases, and assists in the detection of clinically significant cancer. Cortechs.ai’s industry-leading brain imaging software provides radiologists, neurologists, oncologists, and clinical researchers worldwide with a convenient and cost-effective way to quantify brain structures for assessing Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma, and other brain abnormalities. The company has FDA-cleared products for use in helping the diagnosis and follow-up of neurodegenerative and traumatic brain conditions, as well as prostate cancer. Please visit www.cortechs.ai for further information and follow us on Twitter, LinkedIn, and Facebook.

For more information, please contact:
___________
marketing@cortechs.ai
+1 858 459 9700

More Resources

08/19/2026

Brain Metastases Imaging Insights from SNO/ASCO 2026

Explore key insights from SNO/ASCO 2026 on brain metastases imaging, including lesion tracking, volumetric analysis, SRS workflows, and automated segmentation.

08/18/2026

Cortechs.ai Announces FDA Clearance for NeuroQuant® PET: Advancing Molecular Imaging for Cognitive Impairment

NeuroQuant® PET receives FDA 510(k) clearance, advancing quantitative PET imaging for cognitive impairment.

08/04/2026

Cortechs.ai Expands European CE Marking Across AI Imaging Platform, Accelerating Global Growth

Cortechs.ai expands EU CE Marking for the latest NeuroQuant®, NeuroQuant® Brain Tumor, and OnQ™ Prostate, advancing global AI imaging innovation

07/29/2026

Read Your Segmentations in the Same Space You Read the Study: Native Space Outputs in NeuroQuant v5.3.0

Review lesion segmentations directly on your original MRI images with NeuroQuant® v5.3.0.

07/23/2026

What AAIC 2026 Told Us About the Future of Dementia Imaging — And Where NeuroQuant Fits

Quantitative MRI brain volumetry with NeuroQuant.

07/09/2026

Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration

Cortechs.ai and Viz.ai partner to tackle multiple sclerosis and other neurodegenerative diseases across Viz.ai’s health system network
Scroll to Top